The General Business of The Florida PDMP Foundation, Inc.; DATES: March 8, 2013; March 22, 2013; April 5, 2013; April 19, 2013; May 3, 2013; May 17, 2013 TIME: 9:00 to 10:00 a.m. ET; Via Conference Call (888) 670-3525, Conference code: 1648696226
DEPARTMENT OF HEALTH
Prescription Drug Monitoring ProgramThe Florida PDMP Foundation, Inc. announces a public meeting to which all persons are invited.
DATES AND TIME: March 8, 2013; March 22, 2013; April 5, 2013; April 19, 2013; May 3, 2013; May 17, 2013; 9:00 a.m. - 10:00 a.m. ET
PLACE: Via conference call, (888)670-3525, conference code 1648696226
GENERAL SUBJECT MATTER TO BE CONSIDERED: The General Business of The Florida PDMP Foundation, Inc.
A copy of the agenda may be obtained by contacting: The Florida PDMP Foundation, Inc., C/O Florida Prescription Drug Monitoring Program, www.eforcse.com. The public agenda will be available two days prior to the meeting date on this website.
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 10 days before the meeting by contacting: the Prescription Drug Monitoring Program at (850)245-4797. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, (800)955-8771 (TDD) or (800)955-8770 (Voice).
For more information, you may contact: The Florida PDMP Foundation, Inc., C/O Florida Prescription Drug Monitoring Program, 4052 Bald Cypress Way, C-16, Tallahassee, FL 32399, or (850)245-4797.
Document Information
- Hearing Meeting:
- Via Conference Call (888) 670-3525, Conference code: 1648696226
- Subject:
- The General Business of The Florida PDMP Foundation, Inc.
- Meeting:
- public meeting
- Contact:
- A copy of the agenda may be obtained by contacting: The Florida PDMP Foundation, Inc., C/O Florida Prescription Drug Monitoring Program, www.eforcse.com. The public agenda will be available two days prior to the meeting date on this website. Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 10 days before the meeting by contacting: the Prescription Drug ...